An engineered cxcl12 alpha locked dimer polypeptide

Details An engineered cxcl12 alpha locked dimer polypeptide An engineered cxcl12 alpha locked dimer polypeptide

A - Human Necessities

61

K

A61K 38/17 (2006.01) C07K 14/52 (2006.01) C07K 14/715 (2006.01)

Patent

CA 2716615

The present invention provides a novel CXCL12-.alpha.2 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.

Cette invention concerne un nouveau polypeptide dimère CXCL12-a2 bloqué, ses compositions pharmaceutiques et des procédés dutilisation dudit dimère dans le traitement du cancer, des affections inflammatoires, des maladies auto-immunes et du VIH/SIDA.

Affiliated with

Also associated with

Rating

An engineered cxcl12 alpha locked dimer polypeptide does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with An engineered cxcl12 alpha locked dimer polypeptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and An engineered cxcl12 alpha locked dimer polypeptide will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1935449